BioNTech SE American Depositary Share (BNTX)
- Headquarters
- United States
- Employees
- 7,807
- Market Cap
- $24.3B
About BioNTech SE American Depositary Share
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.
SentiSense also tracks daily options readings for BioNTech SE American Depositary Share: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
BioNTech SE American Depositary Share stock analysis, sentiment tracking, and market intelligence on SentiSense.